Skip to main content

Advertisement

SpringerLink
Log in

Finding the Right Osmotic Agent: Why Mannitol Prevailed

  • Neurocritical Care Through History
  • Published:
Neurocritical Care Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

References

  1. Litchfield L. Glucose Intravenously as a therapeutic measure. JAMA. 1918;71:503–5.

    Article  Google Scholar 

  2. Fay T. The administration of hypertonic salt solutions for the relief of intracranial pressure. JAMA. 1923;80(20):1445–8.

    Article  CAS  Google Scholar 

  3. Wilkins RH, Weed LH, McKibben PS. Neurosurgical classic-Xxxii. J Neurosurg. 1965;22:404–19.

    Article  CAS  PubMed  Google Scholar 

  4. Rocque, B. G., Manucher javid, urea, and the rise of osmotic therapy for intracranial pressure. Neurosurgery 2012;70(5):1049–54; discussion 54.

  5. Javid M, Settlage P. Effect of urea on cerebrospinal fluid pressure in human subjects; preliminary report. J Am Med Assoc. 1956;160(11):943–9.

    Article  CAS  PubMed  Google Scholar 

  6. Javid M, Settlage P, Monfore T. Urea in the management of increased intracranial pressure. Surg Forum. 1957;7:528–32.

    CAS  PubMed  Google Scholar 

  7. Javid M. Urea—new use of an old agent: reduction of intracranial and intraocular pressure. SurgClin North America. 1958;38:907–28.

    Article  CAS  Google Scholar 

  8. Decaux G, Andres C, GankamKengne F, Soupart A. Treatment of euvolemichyponatremia in the intensive care unit by urea. Crit Care. 2010;14(5):R184.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Mason MS, Raaf J. Physiological alterations and clinical effects of urea induced diuresis. J Neurosurg. 1961;18:645–53.

    Article  CAS  PubMed  Google Scholar 

  10. Cushing H, Foley FEB. Alterations of intracranial tension by salt solutions in the alimentary canal. ProcSocExpBiol Med. 1920;17:217–8.

    CAS  Google Scholar 

  11. Ebaugh FG, Stevenson GS. Measurements of intracranial pressure changes in an epileptic and its experimental variations. Johns Hopkins Hosp Bull. 1920;31:440.

    Google Scholar 

  12. Foley FEB, Putnam TJ. The effect of salt ingestion on cerebro-spinal fluid pressure and brain volume. Am J Physiol. 1920;53:464–76.

    Article  Google Scholar 

  13. Browder J. Dangers in the use of hypertonic solutions in the treatment of brain injuries. Am J Surg. 1930;8:12–3.

    Article  Google Scholar 

  14. Bullock LT, Gregersen MI, Kinney R. The use of hypertonic sucrose solution intravenously to reduce cerebrospinal fluid pressure without a secondary rise. Am J Physiol. 1935;112:82–96.

    Article  CAS  Google Scholar 

  15. Bernstein LM, Blumberg B, Arkin MC. Osmotic diuretic treatment of refractory Edema. Circulation. 1958;17(6):1013–20.

    Article  CAS  PubMed  Google Scholar 

  16. Barry KG, Berman AR. Mannitol infusion. III. The acute effect of the intravenous infusion of mannitol on blood and plasma volumes. N Engl J Med. 1961;264:1085–8.

    Article  CAS  PubMed  Google Scholar 

  17. Wise BL, Chater N. Use of hypertonic mannitol solutions to lower cerebrospinal fluid pressure and decrease brain bulk in man. Surg Forum. 1961;12:398–9.

    CAS  PubMed  Google Scholar 

  18. Wise BL, Chater N. Effect of mannitol on cerebrospinal fluid pressure. The actions of hypertonic mannitol solutions and of urea compared. Arch Neurol. 1961;4:200–2.

    Article  CAS  PubMed  Google Scholar 

  19. Wise BL, Chater N. The value of hypertonic mannitol solution in decreasing brain mass and lowering cerebro-spinal-fluid pressure. J Neurosurg. 1962;19:1038–43.

    Article  CAS  PubMed  Google Scholar 

  20. Schwartz ML, Tator CH, Rowed DW, et al. The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol. Can J NeurolSci. 1984;11(4):434–40.

    Article  CAS  Google Scholar 

  21. Sayre MR, Daily SW, Stern SA, et al. Out-of-hospital administration of mannitol to head-injured patients does not change systolic blood pressure. AcadEmerg Med. 1996;3(9):840–8.

    CAS  Google Scholar 

  22. Vialet R, Albanese J, Thomachot L, et al. Isovolume hypertonic solutes (sodium chloride or mannitol) in the treatment of refractory posttraumatic intracranial hypertension: 2 mL/kg 7.5% saline is more effective than 2 mL/kg 20% mannitol. Crit Care Med. 2003;31(6):1683–7.

    Article  CAS  PubMed  Google Scholar 

  23. Cooper DJ, Myles PS, McDermott FT, et al. Prehospital hypertonic saline resuscitation of patients with hypotension and severe traumatic brain injury: a randomized controlled trial. JAMA. 2004;291(11):1350–7.

    Article  CAS  PubMed  Google Scholar 

  24. Gu J, Huang H, Huang Y, Sun H, Xu H. Hypertonic saline or mannitol for treating elevated intracranial pressure in traumatic brain injury: a meta-analysis of randomized controlled trials. Neurosurg Rev. 2019;42(2):499–509.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Neurocritical Care and Hospital Neurology, 200 First Street SW, Rochester, MN, 55905, USA

    Eelco F. M. Wijdicks

Authors
  1. Eelco F. M. Wijdicks
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Eelco F. M. Wijdicks.

Ethics declarations

Conflicts of interest

Authors have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the collection “Neurocritical Care Through History”.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wijdicks, E.F.M. Finding the Right Osmotic Agent: Why Mannitol Prevailed. Neurocrit Care 38, 192–195 (2023). https://doi.org/10.1007/s12028-021-01189-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12028-021-01189-1

Search

Navigation